REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41 | -14.6% | 2,590 | +4.3% | 0.00% | – |
| Q2 2023 | $48 | -57.9% | 2,483 | -59.4% | 0.00% | – |
| Q1 2023 | $114 | -45.2% | 6,114 | -33.7% | 0.00% | – |
| Q4 2022 | $208 | -99.9% | 9,224 | -10.0% | 0.00% | – |
| Q3 2022 | $270,000 | +12.5% | 10,251 | +5.2% | 0.00% | – |
| Q2 2022 | $240,000 | +10.1% | 9,746 | +47.9% | 0.00% | – |
| Q1 2022 | $218,000 | +230.3% | 6,588 | +222.9% | 0.00% | – |
| Q4 2021 | $66,000 | -58.8% | 2,040 | -46.9% | 0.00% | – |
| Q3 2021 | $160,000 | +63.3% | 3,839 | +50.8% | 0.00% | – |
| Q2 2021 | $98,000 | +9700.0% | 2,546 | +4796.2% | 0.00% | – |
| Q1 2021 | $1,000 | -98.7% | 52 | -97.0% | 0.00% | – |
| Q4 2020 | $79,000 | +107.9% | 1,759 | +25.4% | 0.00% | – |
| Q3 2020 | $38,000 | -47.2% | 1,403 | -28.9% | 0.00% | – |
| Q2 2020 | $72,000 | +18.0% | 1,972 | +31.8% | 0.00% | – |
| Q4 2019 | $61,000 | -95.5% | 1,496 | -92.1% | 0.00% | -100.0% |
| Q2 2018 | $1,358,000 | – | 18,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |